BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29666124)

  • 1. Generation of a double binary transgenic zebrafish model to study myeloid gene regulation in response to oncogene activation in melanocytes.
    Kenyon A; Gavriouchkina D; Zorman J; Chong-Morrison V; Napolitani G; Cerundolo V; Sauka-Spengler T
    Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural crest state activation in NRAS driven melanoma, but not in NRAS-driven melanocyte expansion.
    McConnell AM; Mito JK; Ablain J; Dang M; Formichella L; Fisher DE; Zon LI
    Dev Biol; 2019 May; 449(2):107-114. PubMed ID: 29883661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated in vivo screen in zebrafish identifies Clotrimazole as targeting a metabolic vulnerability in a melanoma model.
    Precazzini F; Pancher M; Gatto P; Tushe A; Adami V; Anelli V; Mione MC
    Dev Biol; 2020 Jan; 457(2):215-225. PubMed ID: 30998907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish.
    Santoriello C; Gennaro E; Anelli V; Distel M; Kelly A; Köster RW; Hurlstone A; Mione M
    PLoS One; 2010 Dec; 5(12):e15170. PubMed ID: 21170325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset.
    Ceol CJ; Houvras Y; Jane-Valbuena J; Bilodeau S; Orlando DA; Battisti V; Fritsch L; Lin WM; Hollmann TJ; Ferré F; Bourque C; Burke CJ; Turner L; Uong A; Johnson LA; Beroukhim R; Mermel CH; Loda M; Ait-Si-Ali S; Garraway LA; Young RA; Zon LI
    Nature; 2011 Mar; 471(7339):513-7. PubMed ID: 21430779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential oncogenic potential of activated RAS isoforms in melanocytes.
    Whitwam T; Vanbrocklin MW; Russo ME; Haak PT; Bilgili D; Resau JH; Koo HM; Holmen SL
    Oncogene; 2007 Jul; 26(31):4563-70. PubMed ID: 17297468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional profile and chromatin accessibility in zebrafish melanocytes and melanoma tumors.
    Kramer ET; Godoy PM; Kaufman CK
    G3 (Bethesda); 2022 Jan; 12(1):. PubMed ID: 34791221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening.
    Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Parinov S; Gong Z
    Dis Model Mech; 2012 Jan; 5(1):63-72. PubMed ID: 21903676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish.
    Dovey M; White RM; Zon LI
    Zebrafish; 2009 Dec; 6(4):397-404. PubMed ID: 19954345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
    Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
    Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene-Expressing Senescent Melanocytes Up-Regulate MHC Class II, a Candidate Melanoma Suppressor Function.
    van Tuyn J; Jaber-Hijazi F; MacKenzie D; Cole JJ; Mann E; Pawlikowski JS; Rai TS; Nelson DM; McBryan T; Ivanov A; Blyth K; Wu H; Milling S; Adams PD
    J Invest Dermatol; 2017 Oct; 137(10):2197-2207. PubMed ID: 28647344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive RAC activation is not sufficient to initiate melanocyte neoplasia but accelerates malignant progression.
    Dalton LE; Kamarashev J; Barinaga-Rementeria Ramirez I; White G; Malliri A; Hurlstone A
    J Invest Dermatol; 2013 Jun; 133(6):1572-81. PubMed ID: 23337888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Fatty Acid Scavenging and Glycerophospholipid Metabolism Accompany Melanocyte Neoplasia Progression in Zebrafish.
    Henderson F; Johnston HR; Badrock AP; Jones EA; Forster D; Nagaraju RT; Evangelou C; Kamarashev J; Green M; Fairclough M; Ramirez IB; He S; Snaar-Jagalska BE; Hollywood K; Dunn WB; Spaink HP; Smith MP; Lorigan P; Claude E; Williams KJ; McMahon AW; Hurlstone A
    Cancer Res; 2019 May; 79(9):2136-2151. PubMed ID: 30862716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression.
    Wang D; Yang W; Du J; Devalaraja MN; Liang P; Matsumoto K; Tsubakimoto K; Endo T; Richmond A
    Oncogene; 2000 Sep; 19(40):4647-59. PubMed ID: 11030154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway.
    Denoyelle C; Abou-Rjaily G; Bezrookove V; Verhaegen M; Johnson TM; Fullen DR; Pointer JN; Gruber SB; Su LD; Nikiforov MA; Kaufman RJ; Bastian BC; Soengas MS
    Nat Cell Biol; 2006 Oct; 8(10):1053-63. PubMed ID: 16964246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental chromatin programs determine oncogenic competence in melanoma.
    Baggiolini A; Callahan SJ; Montal E; Weiss JM; Trieu T; Tagore MM; Tischfield SE; Walsh RM; Suresh S; Fan Y; Campbell NR; Perlee SC; Saurat N; Hunter MV; Simon-Vermot T; Huang TH; Ma Y; Hollmann T; Tickoo SK; Taylor BS; Khurana E; Koche RP; Studer L; White RM
    Science; 2021 Sep; 373(6559):eabc1048. PubMed ID: 34516843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish.
    Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Lam SH; Mathavan S; Parinov S; Gong Z
    Dis Model Mech; 2011 Nov; 4(6):801-13. PubMed ID: 21729876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two novel small molecules targeting melanocyte development in zebrafish embryogenesis.
    Chen L; Ren X; Liang F; Li S; Zhong H; Lin S
    Pigment Cell Melanoma Res; 2012 Jul; 25(4):446-53. PubMed ID: 22574862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic KRAS promotes malignant brain tumors in zebrafish.
    Ju B; Chen W; Orr BA; Spitsbergen JM; Jia S; Eden CJ; Henson HE; Taylor MR
    Mol Cancer; 2015 Feb; 14(1):18. PubMed ID: 25644510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.